(18)F-FDG-PET Detects Drastic Changes in Brain Metabolism in the Tg4–42 Model of Alzheimer’s Disease

The evaluation of new therapeutic strategies in Alzheimer’s disease (AD) relies heavily on in vivo imaging and suitable animal models that mimic the pathological changes seen in patients. (18)F-Fluorodeoxyglucose ((18)F-FDG)-positron-emission tomography (PET) is a well-established non-invasive imagi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouter, Caroline, Henniges, Philipp, Franke, Timon N., Irwin, Caroline, Sahlmann, Carsten Oliver, Sichler, Marius E., Beindorff, Nicola, Bayer, Thomas A., Bouter, Yvonne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333025/
https://www.ncbi.nlm.nih.gov/pubmed/30670962
http://dx.doi.org/10.3389/fnagi.2018.00425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333025/
https://www.ncbi.nlm.nih.gov/pubmed/30670962
http://dx.doi.org/10.3389/fnagi.2018.00425

Ejemplares similares